pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·2d ago·1 min read
save

‘They’ve been misdiagnosed for too long’: Researchers use 10-protein panel to improve ALS detection

Nov 11, 2026·read at Fierce Biotech ↗

By the time a neurodegenerative condition has been diagnosed, it's often too late. At the point of detection, the disease may already be causing irreversible damage, fueling an urgent search for ways to identify biological clues earlier and track their progression.

source

Reporting by Fierce Biotech.

read at Fierce Biotech ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5h agoRezolute gets an uplift from phase 3 tumor hyperinsulinism win ahead of FDA meetingFierce Biotech
  • 7h agoAmerican Cancer Society updates prostate cancer screening guidanceFierce Biotech
  • 11h agoVirtuoso Surgical nabs FDA authorization for robotic bladder lesions systemFierce Biotech
  • 11h agoSanofi-backed Windward hits $225M IPO goal to advance respiratory drugs from ChinaFierce Biotech
  • 11h agoCellectis will shed 70% of workforce as part of in vivo pivotFierce Biotech